| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $781.5M | — | -1.6% |
| Cost of Revenue | $133.4M | — | +44.2% |
| Gross Profit | $648.1M | — | -7.7% |
| R&D Expense | $138.2M | — | -7.2% |
| SG&A Expense | $184.1M | — | +8.2% |
| Operating Income | $325.8M | — | -14.9% |
| Pre-tax Income | $318.3M | — | -24.8% |
| Income Tax | $43.4M | — | -57.2% |
| Net Income | $274.9M | — | -14.7% |
| EPS (Basic) | $6.32 | — | -12.0% |
| EPS (Diluted) | $5.82 | — | -12.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.28B | -17.8% | -32.6% |
| Short-term Investments | $874.0M | -35.9% | -38.5% |
| Accounts Receivable | $312.0M | -10.9% | -3.1% |
| Inventory | $178.3M | -2.6% | +7.8% |
| Current Assets | $2.87B | -22.4% | -27.1% |
| Total Assets | $6.71B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $463.3M | — | +0.5% |
| Capital Expenditures | $100.8M | — | +34.6% |
| Investing Cash Flow | $743.7M | — | +551.5% |
| Financing Cash Flow | -$1.48B | — | -1482.5% |
| Free Cash Flow | $362.5M | — | -6.2% |
| -13.3% |
| Current Liabilities | $599.1M | +6.9% | -17.0% |
| Total Liabilities | $813.1M | +3.7% | -13.2% |
| Stockholders' Equity | $5.90B | -16.8% | -13.3% |